217 related articles for article (PubMed ID: 37183977)
1. Type-I AIE Photosensitizer Loaded Biomimetic System Boosting Cuproptosis to Inhibit Breast Cancer Metastasis and Rechallenge.
Ning S; Lyu M; Zhu D; Lam JWY; Huang Q; Zhang T; Tang BZ
ACS Nano; 2023 Jun; 17(11):10206-10217. PubMed ID: 37183977
[TBL] [Abstract][Full Text] [Related]
2. Copper-coordinated nanoassemblies based on photosensitizer-chemo prodrugs and checkpoint inhibitors for enhanced apoptosis-cuproptosis and immunotherapy.
Liang W; Han C; Zhang D; Liu C; Zhu M; Xu F; Fang C; Zhang S; Liu C; Li Y
Acta Biomater; 2024 Feb; 175():341-352. PubMed ID: 38122883
[TBL] [Abstract][Full Text] [Related]
3. Photoinduced Cuproptosis with Tumor-Specific for Metastasis-Inhibited Cancer Therapy.
Zheng J; Ge H; Guo M; Zhang T; Hu Q; Yao Q; Long S; Sun W; Fan J; Du J; Peng X
Small; 2024 Mar; 20(10):e2304407. PubMed ID: 37880907
[TBL] [Abstract][Full Text] [Related]
4. A biomimetic cuproptosis amplifier for targeted NIR-II fluorescence/photoacoustic imaging-guided synergistic NIR-II photothermal immunotherapy.
Dai Y; Zhu L; Li X; Zhang F; Chen K; Jiao G; Liu Y; Yang Z; Guo Z; Zhang B; Shen Q; Zhao Q
Biomaterials; 2024 Mar; 305():122455. PubMed ID: 38160626
[TBL] [Abstract][Full Text] [Related]
5. CuO Nanozymes Catalyze Cysteine and Glutathione Depletion Induced Ferroptosis and Cuproptosis for Synergistic Tumor Therapy.
Bai J; Zhang X; Zhao Z; Sun S; Cheng W; Yu H; Chang X; Wang B
Small; 2024 May; ():e2400326. PubMed ID: 38813723
[TBL] [Abstract][Full Text] [Related]
6. A Stimulus-Responsive Ternary Heterojunction Boosting Oxidative Stress, Cuproptosis for Melanoma Therapy.
Huang Y; Chen C; Tan H; Dong S; Ren Y; Chao M; Yan H; Yan X; Jiang G; Gao F
Small; 2024 May; ():e2401147. PubMed ID: 38770990
[TBL] [Abstract][Full Text] [Related]
7. A type I AIE photosensitiser-loaded biomimetic nanosystem allowing precise depletion of cancer stem cells and prevention of cancer recurrence after radiotherapy.
Ning S; Zhang T; Lyu M; Lam JWY; Zhu D; Huang Q; Tang BZ
Biomaterials; 2023 Apr; 295():122034. PubMed ID: 36746049
[TBL] [Abstract][Full Text] [Related]
8. Biomimetic copper-doped polypyrrole nanoparticles induce glutamine metabolism inhibition to enhance breast cancer cuproptosis and immunotherapy.
Zhang N; Ping W; Rao K; Zhang Z; Huang R; Zhu D; Li G; Ning S
J Control Release; 2024 May; 371():204-215. PubMed ID: 38810704
[TBL] [Abstract][Full Text] [Related]
9. Cuproptosis-a potential target for the treatment of osteoporosis.
Li D; Gao Z; Li Q; Liu X; Liu H
Front Endocrinol (Lausanne); 2023; 14():1135181. PubMed ID: 37214253
[TBL] [Abstract][Full Text] [Related]
10. Syphilis mimetic nanoparticles for cuproptosis-based synergistic cancer therapy via reprogramming copper metabolism.
Zhang J; Han M; Zhang J; Abdalla M; Sun P; Yang Z; Zhang C; Liu Y; Chen C; Jiang X
Int J Pharm; 2023 Jun; 640():123025. PubMed ID: 37164186
[TBL] [Abstract][Full Text] [Related]
11. Cuproptosis: p53-regulated metabolic cell death?
Xiong C; Ling H; Hao Q; Zhou X
Cell Death Differ; 2023 Apr; 30(4):876-884. PubMed ID: 36755067
[TBL] [Abstract][Full Text] [Related]
12. Copper homeostasis and cuproptosis in health and disease.
Chen L; Min J; Wang F
Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
[TBL] [Abstract][Full Text] [Related]
13. An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy.
Xu Y; Liu SY; Zeng L; Ma H; Zhang Y; Yang H; Liu Y; Fang S; Zhao J; Xu Y; Ashby CR; He Y; Dai Z; Pan Y
Adv Mater; 2022 Oct; 34(43):e2204733. PubMed ID: 36054475
[TBL] [Abstract][Full Text] [Related]
14. Inhalable metal-organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy.
Yan C; Liu Y; Zhao G; Yang H; Lv H; Li G; Li Y; Fu Y; Sun F; Feng Y; Li Y; Zhao Z
Acta Pharm Sin B; 2024 May; 14(5):2281-2297. PubMed ID: 38799628
[TBL] [Abstract][Full Text] [Related]
15. Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy.
Chang J; Yin W; Zhi H; Chen S; Sun J; Zhao Y; Huang L; Xue L; Zhang X; Zhang T; Dong H; Li Y
Small; 2024 Feb; ():e2308565. PubMed ID: 38339770
[TBL] [Abstract][Full Text] [Related]
16. Cuproptosis: Mechanism, role, and advances in urological malignancies.
Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
[TBL] [Abstract][Full Text] [Related]
17. Copper homeostasis and cuproptosis in cancer immunity and therapy.
Liu WQ; Lin WR; Yan L; Xu WH; Yang J
Immunol Rev; 2024 Jan; 321(1):211-227. PubMed ID: 37715546
[TBL] [Abstract][Full Text] [Related]
18. Cuproptosis is involved in copper-induced hepatotoxicity in chickens.
Zhong G; Li L; Li Y; Ma F; Liao J; Li Y; Zhang H; Pan J; Hu L; Tang Z
Sci Total Environ; 2023 Mar; 866():161458. PubMed ID: 36621474
[TBL] [Abstract][Full Text] [Related]
19. Cuproptosis as the new kryptonite of cancer: a copper-dependent novel cell death mechanism with promising implications for the treatment of hepatocellular carcinoma.
Ozkan E; Bakar-Ates F
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17663-17670. PubMed ID: 37843555
[TBL] [Abstract][Full Text] [Related]
20. Photothermally Triggered Copper Payload Release for Cuproptosis-Promoted Cancer Synergistic Therapy.
Zhou J; Yu Q; Song J; Li S; Li XL; Kang BK; Chen HY; Xu JJ
Angew Chem Int Ed Engl; 2023 Mar; 62(12):e202213922. PubMed ID: 36585379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
